Cargando…
CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion
BACKGROUND: We have previously validated three novel CD44-downstream positively regulated transcriptional targets, including Cortactin, Survivin and TGF-β2, and further characterized the players underlying their separate signaling pathways. In the present study, we identified CD146 as a potential no...
Autores principales: | Ouhtit, Allal, Abdraboh, Mohammed E., Hollenbach, Andrew D., Zayed, Hatem, Raj, Madhwa H. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679321/ https://www.ncbi.nlm.nih.gov/pubmed/29121955 http://dx.doi.org/10.1186/s12964-017-0200-3 |
Ejemplares similares
-
Novel CD44-downstream signaling pathways mediating breast tumor invasion
por: Ouhtit, Allal, et al.
Publicado: (2018) -
TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion
por: Ouhtit, Allal, et al.
Publicado: (2013) -
KYNU, a novel potential target that underpins CD44‐promoted breast tumour cell invasion
por: Al‐Mansoob, Maryam, et al.
Publicado: (2021) -
CD44 mediates stem cell mobilization to damaged lung via its novel transcriptional targets, Cortactin and Survivin
por: Ouhtit, Allal, et al.
Publicado: (2020) -
SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion/metastasis
por: Ahmad, Salma M. S., et al.
Publicado: (2022)